Showing results (771-780 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|June 23, 2015
Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control studyJohn C Chambers, Marie Loh, Benjamin Lehne, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2015
Prevalence of behavioural risk factors for cardiovascular disease in adolescents in low-income and middle-income countries: an individual participant data meta-analysisRishi Caleyachetty, Justin B Echouffo-Tcheugui, Christopher A Tait, et al.
The Lancet. Diabetes & Endocrinology|April 26, 2020
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trialYuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto, et al.
The Lancet. Diabetes & Endocrinology|September 4, 2021
Insulin therapy development beyond 100 yearsPhilip D Home, Roopa Mehta
The Lancet. Diabetes & Endocrinology|November 13, 2022
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trialSilvio E Inzucchi, Brian L Claggett, Muthiah Vaduganathan, et al.
The Lancet. Diabetes & Endocrinology|June 25, 2022
Management of thyroid nodulesErik K Alexander, Gerard M Doherty, Justine A Barletta
The Lancet. Diabetes & Endocrinology|December 17, 2022
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trialsAdem Y Dawed, Andrea Mari, Andrew Brown, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implicationsJesús Argente, Leo Dunkel, Ursula B Kaiser, et al.
The Lancet. Diabetes & Endocrinology|January 9, 2023
Risks and burdens of incident dyslipidaemia in long COVID: a cohort studyEvan Xu, Yan Xie, Ziyad Al-Aly
The Lancet. Diabetes & Endocrinology|July 8, 2022
Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort studyMohamed Ghalwash, Jessica L Dunne, Markus Lundgren, et al.
Pageof 93